You are here

  • Home
  • Archive
  • Volume 94, Issue 4
  • Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

Article metrics

Article menu
Multiple sclerosis
Original research
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

 

Online download statistics by month:

Online download statistics by month: December 2022 to March 2024

AbstractFullPdf
Dec 2022750743178
Jan 2023889865104
Feb 202364364367
Mar 2023647651128
Apr 202326326278
May 202334932777
Jun 202328226442
Jul 202390088946
Aug 202313212022
Sep 2023808122
Oct 2023857329
Nov 20231209244
Dec 20231296244
Jan 20241087659
Feb 2024603829
Mar 2024695636
Total550652421005